VEGFB anticorps (AA 22-207)
Aperçu rapide pour VEGFB anticorps (AA 22-207) (ABIN7175368)
Antigène
Voir toutes VEGFB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 22-207
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Vascular endothelial growth factor B protein (22-207AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VEGFB (Vascular Endothelial Growth Factor B (VEGFB))
-
Autre désignation
- VEGFB
-
Sujet
-
Background: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.
Aliases: Vascular endothelial growth factor B antibody, Vascular endothelial growth factor-related factor antibody, VEGF B antibody, VEGF related factor antibody, VEGF-B antibody, VEGF-related factor antibody, Vegfb antibody, VEGFB_HUMAN antibody, VEGFL antibody, VRF antibody
-
UniProt
- P49765
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-